Precision Medicine

By Jessica Davis 01:11 pm April 04, 2017
According to the media company’s lawyers, the biotech billionaire told Tronc leaders that they had to invest in his company to secure his own financial backing.
Pop Health Forum in Boston 2017
By Tom Sullivan 11:48 am April 03, 2017
Focus on analytics, data and maintaining patient access, speakers at the Pop Health Forum in Boston say.
precision medicine survey
By Bill Siwicki 08:55 am April 03, 2017
Precision medicine holds the promise of combatting diseases in whole new ways, but the barrier to entry is pretty high.
NantHealth Patrick Soon-Shiong
By Jessica Davis 01:37 pm March 31, 2017
Lack of sales from its GPC Cancer diagnostic test dragged down finances as the company continues to face public scrutiny.

Andrew Pecora, MD

By Mike Miliard 11:09 am March 27, 2017
The multi-year research agreement will see the pharmaceutical company putting Cota's analytics platform to work for improved breast cancer treatment outcomes.
Intermountain predicting chronic disease

Heidi May, cardiovascular epidemiologist at the Intermountain Medical Center Heart Institute, led research into the predictors of chronic illnesses.

By Bernie Monegain 02:14 pm March 20, 2017
Researchers say the Intermountain Chronic Disease Risk Score can predict which patients will receive a first diagnosis within three years.
Intel artificial intelligence cancer
By Jack McCarthy 09:39 am March 16, 2017
Company officials said the competition offers a total of $100,000 for three winners, with first place taking $50,000. 
By Jessica Davis 05:18 pm March 14, 2017
Two Advisory Board research leaders discuss the current state of precision medicine – and what it will take for genomics to become part of routine care.
genomics patient generated health data
By Jack McCarthy 09:42 am March 13, 2017
The lack of adequate EHR interoperability continues to hinder healthcare organizations ability to use patient data in care delivery, the report’s author said. 
NantHealth Soon-Shiong

Patrick Soon-Shiong, MD

By Jessica Davis 11:51 am March 09, 2017
A single investor is suing the biotech mogul and NantHealth, alleging violation of federal securities laws. Other law firms have also filed class action suits against the company.

Most Read

The Daily Brief Newsletter